Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neuroblastoma 5Prostatic Neoplasms 3Skin Neoplasms 2Precancerous Conditions 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Stomach Neoplasms 1Sarcoma, Ewing 1Osteosarcoma 1Non-melanoma Skin Cancer 1Neoplasms 1Medulloblastoma 1Keratosis, Actinic 1Gastritis, Atrophic 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Basal Cell 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

Diclofenac 2Eflornithine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Non-melanoma Skin Cancer × Eflornithine × Clear all
NCT04091022 2025-12-17

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

University of Alabama at Birmingham

Phase 2 Completed
64 enrolled
Dermatologic

Non-melanoma Skin Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡